Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
The Lancet. Haematology
View this publicationThe Lancet. Haematology
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationJournal of thrombosis and haemostasis : JTH
View this publicationJournal of thrombosis and haemostasis : JTH
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationResearch and practice in thrombosis and haemostasis
View this publicationTherapeutic advances in hematology
View this publicationEuropean journal of haematology
View this publicationAdvances in therapy
View this publicationTH open : companion journal to thrombosis and haemostasis
View this publication